Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) SHH
58.74
-1.86(-3.07%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
58.74
-1.86(-3.07%)
Currency In CNY
Address
No. 399, Libing Road
Shanghai, 201203
China
Phone
86 21 8029 7676
Website
Sector
Healthcare
Industry
Biotechnology
Employees
995
First IPO Date
July 22, 2020
| Name | Title | Pay | Year Born |
| Hongmei Niu | Chief Financial Officer | 0 | 1990 |
| Lirong Zheng | Accounting Supervisor | 0 | N/A |
| Qi Zhang | Secretary of Board of Directors | 0 | 1984 |
| Yanli Liu | GM & Director | 0 | 1981 |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China.